WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory…
WARREN, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), announced today…
Collaboration in Singapore aims to further expand the broad potential of Life Bio’s Partial Epigenetic Reprogramming Platform as part of…
July 02, 2025 06:00 ET | Source: Instil Bio US phase 1 trial of ‘2510 is expected to be initiated before…
July 02, 2025 03:00 ET | Source: Belite Bio, Inc - 500 subjects enrolled across the United States, the United…
Phase 1 data evaluating VRB-101, Verdiva Bio’s cAMP-biased oral GLP-1RA, provides proof of concept for potential once-weekly oral administration. Preclinical…
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia has concluded its landmark debut at the BIO International Convention 2025,…
SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings LLC ("Parataxis Holdings"), an affiliate of Parataxis Capital…
June 06, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…
June 05, 2025 16:58 ET | Source: Boundless Bio, Inc. SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Boundless Bio…